Cancer-associated adipocytes promotes breast tumor radioresistance

Biochemical and Biophysical Research Communications

Volumn 411, Issue 1, 2011, Pages 102-106

  Bochet, Ludivine ^a,b,c   Meulle, Aline ^a,b,c   Imbert, Sandrine ^b   Salles, Bernard ^a,b   Valet, Philippe ^a,c   Muller, Catherine ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c INSERM   (France)

Author keywords

Adipocytes; Breast cancer; Interleukin 6; Ionizing radiation; Radioresistance

Indexed keywords

ADIPOCYTOKINE; CHECKPOINT KINASE 1; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BREAST TUMOR; CANCER RADIOTHERAPY; HUMAN; HUMAN CELL; INFRARED RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR GROWTH;

ADIPOCYTES; ANIMALS; BREAST NEOPLASMS; CELL SURVIVAL; COCULTURE TECHNIQUES; FEMALE; HUMANS; INTERLEUKIN-6; MICE; PROTEIN KINASES; RADIATION TOLERANCE;

EID: 79960555932     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.101     Document Type: Article

References (32)

1. Haffty B.G., Glazer P.M. Molecular markers in clinical radiation oncology. Oncogene 2003, 22:5915-5925.
2. Ashwell S., Janetka J.W., Zabludoff S. Keeping checkpoint kinases in line: new selective inhibitors in clinical trials. Expert Opin. Investig. Drugs 2008, 17:1331-1340.
3. Ross G.M. Induction of cell death by radiotherapy. Endocr. Relat. Cancer 1999, 6:41-44.
4. Mueller M.M., Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004, 4:839-849.
5. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002, 296:1046-1049.
6. Rajala M.W., Scherer P.E. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144:3765-3773.
7. Dirat B., Bochet L., Escourrou G., Valet P., Muller C. Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes?. Endocr. Dev. 2010, 19:45-52.
8. Dirat B., Bochet L., Dabek M., Daviaud D., Dauvillier S., Majed B., Wang Y.Y., Meulle A., Salles B., Le Gonidec S., Garrido I., Escourrou G., Valet P., Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011, 71:2455-2465.
9. Barcellos-Hoff M.H., Ravani S.A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 2000, 60:1254-1260.
10. Tsai K.K., Stuart J., Chuang Y.Y., Little J.B., Yuan Z.M. Low-dose radiation-induced senescent stromal fibroblasts render nearby breast cancer cells radioresistant. Radiat. Res. 2009, 172:306-313.
11. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., Fuks Z., Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
12. Paris F., Fuks Z., Kang A., Capodieci P., Juan G., Ehleiter D., Haimovitz-Friedman A., Cordon-Cardo C., Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001, 293:293-297.
13. Meng Y., Beckett M.A., Liang H., Mauceri H.J., van Rooijen N., Cohen K.S., Weichselbaum R.R. Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. Cancer Res. 2010, 70:1534-1543.
14. Meulle A., Salles B., Daviaud D., Valet P., Muller C. Positive regulation of DNA double strand break repair activity during differentiation of long life span cells: the example of adipogenesis. PLoS ONE 2008, 3:e3345.
15. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 23:2825-2837.
16. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., Ayav A., Ziegler O., Carpene C., Saulnier-Blache J.S., Valet P., Castan-Laurell I. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006, 20:1528-1530.
17. Bouquet F., Muller C., Salles B. The loss of gammaH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage. Cell Cycle 2006, 5:1116-1122.
18. Green H., Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 1976, 7:105-113.
19. Tao Y., Leteur C., Yang C., Zhang P., Castedo M., Pierre A., Golsteyn R.M., Bourhis J., Kroemer G., Deutsch E. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints. Cell Cycle 2009, 8:1196-1205.
20. Niida H., Katsuno Y., Banerjee B., Hande M.P., Nakanishi M. Specific role of Chk1 phosphorylations in cell survival and checkpoint activation. Mol. Cell. Biol. 2007, 27:2572-2581.
21. Deorukhkar A., Krishnan S. Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol. 2010, 80:1904-1914.
22. Behan J.W., Yun J.P., Proektor M.P., Ehsanipour E.A., Arutyunyan A., Moses A.S., Avramis V.I., Louie S.G., Butturini A., Heisterkamp N., Mittelman S.D. Adipocytes impair leukemia treatment in mice. Cancer Res. 2009, 69:7867-7874.
23. Braunschweiger P.G., Basrur V., Santos O., Adessa A., Houdek P., Markoe A.M. Radioresistance in murine solid tumors induced by interleukin-1. Radiat. Res. 1996, 145:150-156.
24. Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A., Ji B., Evans D.B., Logsdon C.D. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008, 68:918-926.
25. Neta R., Perlstein R., Vogel S.N., Ledney G.D., Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J. Exp. Med. 1992, 175:689-694.
26. Dubost J.J., Rolhion C., Tchirkov A., Bertrand S., Chassagne J., Dosgilbert A., Verrelle P. Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation. J. Neurooncol. 2002, 56:29-34.
27. Efimova E.V., Liang H., Pitroda S.P., Labay E., Darga T.E., Levina V., Lokshin A., Roizman B., Weichselbaum R.R., Khodarev N.N. Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int. J. Radiat. Biol. 2009, 85:421-431.
28. Murray P.J. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 2007, 178:2623-2629.
29. Aggarwal B.B., Kunnumakkara A.B., Harikumar K.B., Gupta S.R., Tharakan S.T., Koca C., Dey S., Sung B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann. N. Y. Acad. Sci. 2009, 1171:59-76.
30. Hu B., Zhou X.Y., Wang X., Zeng Z.C., Iliakis G., Wang Y. The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway. J. Biol. Chem. 2001, 276:17693-17698.
31. Jin Z.H., Kurosu T., Yamaguchi M., Arai A., Miura O. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 2005, 24:1973-1981.
32. Zhang J., Choi Y., Mavromatis B., Lichtenstein A., Li W. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Oncogene 2003, 22:6289-6295.